About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in California | 874 Studies

Clinical Trials Colorectal CancerCalifornia

Colorectal Cancer Clinical Trials in California

Find 874 clinical trials for colorectal cancer near California. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 874 trials

No longer availableRegorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard TherapyThis is a phase III B, prospective, interventional, open-label, single-arm, multicenter study to provide regorafenib to subjects diagnosed with metastatic colorectal cancer who…NCT01538680·Duarte, California and 206 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedDurvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the LiverThis pilot clinical trial studies the side effects and how well durvalumab and tremelimumab work in treating patients with microsatellite stable colorectal cancer that has spread…NCT03005002·Duarte, California

CompletedDetection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseThis study aims to determine the performance of the Exact IBD-ACRN surveillance test to detect colorectal cancer (CRC) and colorectal neoplasia in patients with inflammatory bowel…NCT01819766·Phoenix, Arizona and 25 others

CompletedA Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic CancerCI-1040 is an experimental drug that is being tested in patients who have advanced colorectal and lung cancer who failed no more than one prior chemotherapy regimen, breast cancer…NCT00034827·Birmingham, Alabama and 29 others

RecruitingStudy of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsThis study is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors.NCT06040541·Sacramento, California and 16 others

UnknownExamination of Trends in Colorectal Cancer Patients' Clinical Study ExperiencesClinical study participation percentages haven't always been fully representative of a given demographic.NCT05891730·San Francisco, California

UnknownA Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesTo determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.NCT00057395·Santa Monica, California

CompletedA Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line RegimenThe study is designed to demonstrate that the combination of AG-013736 with either FOLFIRI or FOLFOX is superior to FOLFIRI or FOLFOX in combination with bevacizumab (Avastin) in…NCT00615056·Mobile, Alabama and 82 others

CompletedAzacitidine and Entinostat in Treating Patients With Metastatic Colorectal CancerThis phase II trial is studying how well giving azacitidine together with entinostat works in treating patients with metastatic colorectal cancer.NCT01105377·Scottsdale, Arizona and 13 others

Completed18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyThe purpose of the study is to conduct research of a new PET radiopharmaceutical in cancer patients.NCT01806675·Stanford, California

SuspendedSafety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon CancerThis is a multicenter, two-stage trial with the goal of evaluating up to 100 subjects.NCT00443573·Los Angeles, California

CompletedOpen-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal CancerThe objective of this trial is to evaluate the safety and tolerability of BI 695502 in combination with leucovorin/5-fluorouracil/oxaliplatin (mFOLFOX6) and as maintenance therapy…NCT02776683·Phoenix, Arizona and 45 others

CompletedSWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003254·Mobile, Alabama and 85 others

CompletedQUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal CarcinomaThis is a phase 2, multicenter, randomized, double-blind, double-dummy, placebo-controlled, three-arm trial to be conducted in the United States, Europe, and Asia.NCT00813605·Beverly Hills, California and 66 others

CompletedBevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal CancerThe purpose of this study is to evaluate the safety and effectiveness of the bevacizumab and capecitabine combination in frail patients with untreated metastatic colorectal cancer.NCT00203411·Alhambra, California and 11 others

CompletedGene Testing in Patients With Colon CancerRATIONALE: Analyzing the structure of genes found in a person's cancer cells may help doctors improve methods of treating patients with colon cancer.NCT00003571·Birmingham, Alabama and 43 others

CompletedStudy Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer TreatmentsThis study will test if there is any survival benefit in patients with refractory metastatic colorectal cancer that receive CP-751, 871.NCT00560560·San Francisco, California and 11 others

CompletedA Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal CancerThis is an international multi-center, prospective, open-label, randomized, adaptive design phase 3 trial of the cancer stem cell pathway inhibitor napabucasin plus standard…NCT02753127·Birmingham, Alabama and 210 others

CompletedStudy of NKTR 255 in Combination With Cetuximab in Solid TumorsThis is a Phase 1b/2, open-label multicenter study evaluating NKTR-255 as a monotherapy and together with cetuximab in patients with head and neck squamous cell carcinoma (HNSCC)…NCT04616196·San Diego, California and 5 others

CompletedA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersThis is a first-in-human, Phase 1, multicenter, open-label, dose-escalation study to establish the maximum-tolerated dose (MTD) or recommended dosage (RD) of ZW49, the…NCT03821233·Duarte, California and 15 others

PreviousPage 5 of 44Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma